z-logo
Premium
Patients at risk of onychomycosis – risk factor identification and active prevention
Author(s) -
Tosti A,
Hay R,
ArenasGuzmán R
Publication year - 2005
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/j.1468-3083.2005.01282.x
Subject(s) - medicine , dermatophyte , trichophyton rubrum , risk factor , nail (fastener) , intensive care medicine , patient education , risk assessment , antifungal , dermatology , surgery , family medicine , materials science , metallurgy , computer security , computer science
ABSTRACT Objectives  The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high‐risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions  Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re‐infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high‐risk group were discussed:•  Immunosuppressed patients ◆  Usual dose and treatment length not appropriate ◆  Follow‐up required ◆  Beware of drug interactions•  Diabetics ◆  Prophylactic foot care combined with nail treatment ◆  Good opportunity for patient education, footwear, foot care, etc. ◆  Beware of drug interactions•  Psoriatics and patients with abnormal nails ◆  Dermatophyte eradication does not restore normal nails•  Children ◆  High failure rate possibly due to compliance problems.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here